Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40


EGFR gene mutation study in cytology specimens.

Ma ES, Ng WK, Wong CL.

Acta Cytol. 2012;56(6):661-8. doi: 10.1159/000343606. Epub 2012 Nov 24. Review.


Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.

Khode R, Larsen DA, Culbreath BC, Parrish S, Walker KL, Sayage-Rabie L, Beissner RS, Rao A.

Cancer Cytopathol. 2013 Jul;121(7):361-9. doi: 10.1002/cncy.21273. Epub 2013 Jan 30.


Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.

Hasanovic A, Ang D, Moreira AL, Zakowski MF.

Lung Cancer. 2012 Aug;77(2):299-305. doi: 10.1016/j.lungcan.2012.04.004. Epub 2012 Apr 26.


Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.

Brachtel EF, Iafrate AJ, Mark EJ, Deshpande V.

Diagn Cytopathol. 2007 May;35(5):257-62.


Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.

Kanaji N, Bandoh S, Ishii T, Tadokoro A, Watanabe N, Takahama T, Haba R, Imataki O, Dobashi H, Matsunaga T.

Lung Cancer. 2012 Aug;77(2):293-8. doi: 10.1016/j.lungcan.2012.03.018. Epub 2012 Apr 10.


EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.

Wei EX, Anga AA, Martin SS, Jackson JG, Nordberg ML, Herrera GA, Turbat-Herrera EA.

Mod Pathol. 2007 Sep;20(9):905-13. Epub 2007 Jul 20.


Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.

Tanaka T, Nagai Y, Miyazawa H, Koyama N, Matsuoka S, Sutani A, Huqun, Udagawa K, Murayama Y, Nagata M, Shimizu Y, Ikebuchi K, Kanazawa M, Kobayashi K, Hagiwara K.

Cancer Sci. 2007 Feb;98(2):246-52.


Evaluation of EGFR mutation status in cytology specimens: an institutional experience.

Aisner DL, Deshpande C, Baloch Z, Watt CD, Litzky LA, Malhotra B, Sepulveda AR, Langer C, Evans T, Van Deerlin VM.

Diagn Cytopathol. 2013 Apr;41(4):316-23. doi: 10.1002/dc.21851. Epub 2011 Nov 18.


Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

Kim HJ, Lee KY, Kim YC, Kim KS, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Lee JC, Lee JE, Kim SY.

Lung Cancer. 2012 Mar;75(3):321-5. doi: 10.1016/j.lungcan.2011.08.005. Epub 2011 Sep 17.


EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.

da Cunha Santos G, Saieg MA, Geddie W, Leighl N.

Cancer Cytopathol. 2011 Apr 25;119(2):80-91. doi: 10.1002/cncy.20150. Epub 2011 Mar 11. Review.


Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer.

Dahabreh IJ, Linardou H, Siannis F, Kosmidis P, Bafaloukos D, Murray S.

Clin Cancer Res. 2010 Jan 1;16(1):291-303. doi: 10.1158/1078-0432.CCR-09-1660. Epub 2009 Dec 22. Review.


[Predictive EGFR gene analyses in cytology].

Bubendorf L, Savic S.

Pathologe. 2009 Dec;30 Suppl 2:136-9. doi: 10.1007/s00292-009-1191-7. German.


EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.

Smouse JH, Cibas ES, Jänne PA, Joshi VA, Zou KH, Lindeman NI.

Cancer. 2009 Feb 25;117(1):67-72. doi: 10.1002/cncy.20011.


Suitability of small bronchoscopic tumour specimens for lung cancer genotyping.

Dooms C, Vliegen L, Vander Borght S, Yserbyt J, Hantson I, Verbeken E, Wauters E, Nackaerts K, Ninane V, Vansteenkiste J, Vandenberghe P.

Respiration. 2014;88(5):371-7. doi: 10.1159/000366136. Epub 2014 Oct 9.


The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.

Yamada N, Oizumi S, Asahina H, Shinagawa N, Kikuchi E, Kikuchi J, Sakakibara-Konishi J, Tanaka T, Kobayashi K, Hagiwara K, Nishimura M.

Oncology. 2012;82(6):341-6. doi: 10.1159/000338327. Epub 2012 Jun 2.


Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors.

Cohen V, Agulnik JS, Ang C, Kasymjanova G, Batist G, Small D, Brandao G, Chong G, Miller WH Jr.

Cancer. 2010 Sep 15;116(18):4309-17. doi: 10.1002/cncr.25214.


Tumor gene mutations and messenger RNA expression: correlation with clinical response to icotinib hydrochloride in non-small cell lung cancer.

Ren GJ, Zhao YY, Zhu YJ, Xiao Y, Xu JS, Shan B, Zhang L.

Chin Med J (Engl). 2011 Jan;124(1):19-25.


Molecular characterization by immunocytochemistry of lung adenocarcinoma on cytology specimens.

Moreira AL, Hasanovic A.

Acta Cytol. 2012;56(6):603-10. doi: 10.1159/000339794. Epub 2012 Nov 24. Review.


Supplemental Content

Support Center